GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Claritev Corp (NYSE:CTEV) » Definitions » Market Cap

CTEV (Claritev) Market Cap : $716.3 Mil (As of Jun. 28, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Claritev Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Claritev's share price for the quarter that ended in Mar. 2025 was $20.63. Claritev's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 16.4 Mil. Therefore, Claritev's market cap for the quarter that ended in Mar. 2025 was $339.1 Mil.

Claritev's quarterly market cap increased from Sep. 2024 ($123.5 Mil) to Dec. 2024 ($239.3 Mil) and increased from Dec. 2024 ($239.3 Mil) to Mar. 2025 ($339.1 Mil).

Claritev's annual market cap increased from Dec. 2022 ($735.0 Mil) to Dec. 2023 ($933.6 Mil) but then declined from Dec. 2023 ($933.6 Mil) to Dec. 2024 ($239.3 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Claritev's Enterprise Value for Today is $5,311.4 Mil.


Claritev Market Cap Historical Data

The historical data trend for Claritev's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Claritev Market Cap Chart

Claritev Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial 5,234.09 2,827.76 735.03 933.58 239.26

Claritev Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 522.58 250.80 123.55 239.26 339.07

Competitive Comparison of Claritev's Market Cap

For the Health Information Services subindustry, Claritev's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Claritev's Market Cap Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Claritev's Market Cap distribution charts can be found below:

* The bar in red indicates where Claritev's Market Cap falls into.


;
;

Claritev Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Claritev's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=$14.78*16.188
=$239.3

Claritev's Market Cap for the quarter that ended in Mar. 2025 is calculated as

Market Cap (Q: Mar. 2025 )=Share Price (Q: Mar. 2025 )*Shares Outstanding (EOP) (Q: Mar. 2025 )
=$20.63*16.436
=$339.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Claritev  (NYSE:CTEV) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Claritev Market Cap Related Terms

Thank you for viewing the detailed overview of Claritev's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Claritev Business Description

Traded in Other Exchanges
N/A
Address
7900 Tysons One Place, Suite 400, McLean, VA, USA, 22102
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Executives
Michael Kim officer: See Remarks POLARIS PARENT CORP, 115 FIFTH AVENUE, NEW YORK NY 10003
Anthony Jr Colaluca director MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
John Michael Prince director 115 FIFTH AVE., NEW YORK NY 10003
Nutter Carol officer: SVP, Chief People Officer 115 FIFTH AVE., NEW YORK NY 10003
Mark Tabak director, officer: Chief Executive Officer 115 FIFTH AVENUE, NEW YORK NY 10003
Michael K. Attal director 425 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
James M Head officer: EVP & Chief Financial Officer 3001 COLORADO BLVD, DENTON TX 76210
Julie D Klapstein director 1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
C Martin Harris director
H&f Corporate Investors Viii, Ltd. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
Music Investments Gp, Llc 10 percent owner C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Music Investments, L.p. 10 percent owner C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Glenn R August director C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Paul Galant officer: President, New Markets 88 WEST PLUMERIA DRIVE, SAN JOSE CA 95134
Michael Stuart Klein director, 10 percent owner, officer: Chief Executive Officer C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017